Sharon Muzerengi
Affiliations: | 2015-2017 | Institute for Clinical Sciences | University of Birmingham (UK) |
Google:
"Sharon Muzerengi"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Gray R, Patel S, Ives N, et al. (2021) Long-term Effectiveness of Adjuvant Treatment With Catechol-O-Methyltransferase or Monoamine Oxidase B Inhibitors Compared With Dopamine Agonists Among Patients With Parkinson Disease Uncontrolled by Levodopa Therapy: The PD MED Randomized Clinical Trial. Jama Neurology |
| Muzerengi S, Rick C, Begaj I, et al. (2017) Coding accuracy for Parkinson's disease hospital admissions: implications for healthcare planning in the UK. Public Health. 146: 4-9 |
| Muzerengi S, Herd C, Rick C, et al. (2016) A systematic review of interventions to reduce hospitalisation in Parkinson's disease. Parkinsonism & Related Disorders. 24: 3-7 |
| Muzerengi S, Herd C, Rick C, et al. (2016) Review of interventions to reduce hospitalisation in Parkinson's disease Parkinsonism & Related Disorders. 22 |
| Muzerengi S, Woolley R, Rick C, et al. (2016) Hospitalisation in early Parkinson's disease using Hospital Episodes Statistics from the PD MED trial Parkinsonism & Related Disorders. 22 |
| Muzerengi S, Clarke CE. (2015) Initial drug treatment in Parkinson's disease. Bmj (Clinical Research Ed.). 351: h4669 |
| Xin Y, Clarke CE, Muzerengi S, et al. (2014) Treatment Reasons, Resource use and Costs of Hospitalisations in People with Parkinson's: Results from a Large Rct. Value in Health : the Journal of the International Society For Pharmacoeconomics and Outcomes Research. 17: A809 |
| Muzerengi S, Contrafatto D, Chaudhuri KR. (2007) Non-motor symptoms: identification and management. Parkinsonism & Related Disorders. 13: S450-6 |